Abcam has appointed Jeffrey Iliffe, a highly experienced finance professional with a track record in the City, the healthcare industry and in e-commerce as its new Chief Financial Officer. Mr Iliffe, who has been working as a financial consultant at Abcam for the past 4 months, will join the Company’s Board on 20 November 2007.
Mr Iliffe’s appointment is the result of a planned succession in which, as previously announced, Eddie Powell will leave the Company on 20 November 2007 after almost eight years as Chief Financial Officer.
Jeffrey Michel Iliffe, age 45, is a qualified accountant who worked as a corporate financier in life sciences at Panmure Gordon & Co between 1989 and 1996. He then moved into industry, holding a number of financial positions at companies including the environmental consultancy Enviros Group Limited and the biotechnology company Plethora Solutions plc. Prior to joining Abcam as a financial consultant, he was chief financial officer at St Minver Limited, an e-commerce company that operates online gaming networks.
Mr Iliffe’s broad financial experience, including acquisitions, business integration and investor relations, is expected to be of significant value to Abcam as the Company continues to execute its strategy to become the world’s largest online antibody resource.
David Cleevely, Abcam’s Chairman, said: “I am delighted to announce the appointment of Jeff Iliffe as Chief Financial Officer and to welcome him to Abcam’s Board. I have worked closely with Jeff for the past four months and have been very impressed by his energy and ability. His broad financial experience, combined with his specific knowledge of e-commerce, means that he is ideally qualified to make an important contribution to the ongoing development of the Company.”